Free Trial

LogicMark (LGMK) Competitors

LogicMark logo
$0.02 0.00 (-3.54%)
As of 03:35 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LGMK vs. BJDX, TIVC, VERO, NAYA, AVGR, QNRX, HSDT, AFIB, NVIVQ, and STSS

Should you be buying LogicMark stock or one of its competitors? The main competitors of LogicMark include Bluejay Diagnostics (BJDX), Tivic Health Systems (TIVC), Venus Concept (VERO), NAYA Biosciences (NAYA), Avinger (AVGR), Quoin Pharmaceuticals (QNRX), Helius Medical Technologies (HSDT), Acutus Medical (AFIB), Invivo Therapeutics (NVIVQ), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry.

LogicMark vs.

Bluejay Diagnostics (NASDAQ:BJDX) and LogicMark (NASDAQ:LGMK) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, community ranking and risk.

Bluejay Diagnostics has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500.

Bluejay Diagnostics has higher earnings, but lower revenue than LogicMark. Bluejay Diagnostics is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluejay Diagnostics$250K8.21-$9.95M-$1.37 thousand0.00
LogicMark$10.08M0.01-$14.55M-$223.500.00

Bluejay Diagnostics has a net margin of 0.00% compared to LogicMark's net margin of -141.96%. LogicMark's return on equity of -124.91% beat Bluejay Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Bluejay DiagnosticsN/A -155.67% -117.82%
LogicMark -141.96%-124.91%-92.05%

Bluejay Diagnostics received 2 more outperform votes than LogicMark when rated by MarketBeat users.

CompanyUnderperformOutperform
Bluejay DiagnosticsOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
LogicMarkN/AN/A

In the previous week, LogicMark had 1 more articles in the media than Bluejay Diagnostics. MarketBeat recorded 4 mentions for LogicMark and 3 mentions for Bluejay Diagnostics. Bluejay Diagnostics' average media sentiment score of 1.43 beat LogicMark's score of 0.36 indicating that Bluejay Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Bluejay Diagnostics Positive
LogicMark Neutral

18.5% of Bluejay Diagnostics shares are owned by institutional investors. Comparatively, 7.9% of LogicMark shares are owned by institutional investors. 0.4% of Bluejay Diagnostics shares are owned by insiders. Comparatively, 1.3% of LogicMark shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

LogicMark beats Bluejay Diagnostics on 8 of the 14 factors compared between the two stocks.

Remove Ads
Get LogicMark News Delivered to You Automatically

Sign up to receive the latest news and ratings for LGMK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LGMK vs. The Competition

MetricLogicMarkSurgical appliances & supplies IndustryIndustrials SectorNASDAQ Exchange
Market Cap$96,000.00$8.90B$6.83B$7.87B
Dividend YieldN/A1.42%3.55%4.05%
P/E Ratio0.0018.2821.6918.73
Price / Sales0.0169.2975.1189.10
Price / CashN/A19.6726.7834.64
Price / Book0.005.413.664.14
Net Income-$14.55M$284.66M$793.46M$246.93M
7 Day PerformanceN/A-5.03%-0.79%-3.25%
1 Month PerformanceN/A-5.75%-1.64%-6.24%
1 Year PerformanceN/A-22.45%17.01%-1.44%

LogicMark Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LGMK
LogicMark
0.4246 of 5 stars
$0.02
-3.5%
N/A-99.9%$96,000.00$10.08M0.0020News Coverage
High Trading Volume
BJDX
Bluejay Diagnostics
1.117 of 5 stars
$3.93
-6.2%
N/A-98.8%$2.17M$250,000.000.009Earnings Report
Gap Down
TIVC
Tivic Health Systems
0.5864 of 5 stars
$3.41
-3.9%
N/A-88.0%$2.09M$957,000.000.0010Short Interest ↓
Positive News
Gap Down
VERO
Venus Concept
0.4575 of 5 stars
$3.11
+0.3%
N/A-63.3%$2.05M$67.20M-0.39410Earnings Report
Upcoming Earnings
Short Interest ↑
News Coverage
NAYA
NAYA Biosciences
N/A$2.41
-12.0%
$24.00
+895.9%
N/A$1.61M$6.23M0.0010High Trading Volume
AVGR
Avinger
N/A$0.47
flat
N/AN/A$1.57M$7.26M-0.0470
QNRX
Quoin Pharmaceuticals
1.1091 of 5 stars
$0.30
-1.3%
N/A-76.4%$1.50MN/A-0.074
HSDT
Helius Medical Technologies
0.2464 of 5 stars
$0.40
-8.1%
N/A-93.1%$1.47M$502,000.00-0.0630Earnings Report
Gap Up
AFIB
Acutus Medical
N/A$0.05
+3.9%
N/A-77.3%$1.42M$7.16M0.00340
NVIVQ
Invivo Therapeutics
N/A$0.37
flat
N/AN/A$1.15MN/A0.006High Trading Volume
STSS
Sharps Technology
0.1715 of 5 stars
$0.17
-21.6%
N/AN/A$938,000.00N/A-0.023Earnings Report
Upcoming Earnings
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:LGMK) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners